Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB

Yulia N. Demchenko, Leslie A. Brents, Zhihong Li, Leif P. Bergsagel, Lawrence R. McGee, Michael W. Kuehl

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB'. Together they form a unique fingerprint.

Medicine & Life Sciences